💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @FlashAlert_me | 5 |
| @humour_humourrr | 4 |
| @mediasentiment | 3 |
| @StockTexts | 3 |
Recent Tweets for DRNA
 |
@mediasentiment $DRNA new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 1002 April 19th 2021, 11:04pm |
|
@mediasentiment $DRNA new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 964 April 19th 2021, 8:04pm |
 |
@humour_humourrr $DRNA unbelievably strong in current small cap biotech tape. I guess whoever wanted to exit did so at $20 or below. https://t.co/drbBeXJr78 April 19th 2021, 4:04pm |
 |
@Tickeron $DRNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/yokeU1pNEr April 18th 2021, 10:04am |
 |
@Jarvis_Alerts $DRNA [Dicerna Pharmaceuticals]: Goldman Sachs Initiates Coverage On Buy Announces Price Target $48 https://t.co/pdZY9VQTdY April 17th 2021, 8:04am |
|
@Tickeron $DRNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/7OkVP6PDBZ April 17th 2021, 4:04am |
 |
@MarcJacksonLA $DRNA Goldman Sachs Initiates Coverage On Dicerna Pharmaceuticals With A Buy Rating, $48 PT https://t.co/N7Jcab26HK April 16th 2021, 1:04pm |
|
@Jarvis_Alerts $DRNA (Dicerna Pharmaceuticals): Goldman Sachs Initiates Coverage On Buy 'Announces' Price Target $48 https://t.co/zho5nqpPfc April 16th 2021, 10:04am |
 |
@stockhoot $DRNA Goldman Sachs Initiates Coverage On to Buy : PT $48.00 https://t.co/YxUWL00Oy5 April 16th 2021, 10:04am |
 |
@sbwcws Dicerna initiated with a Buy at Goldman Sachs $DRNA April 16th 2021, 8:04am |
 |
@CashFlow_Fool Bought $DRNA (0.05%): added to HSA account & will add over time; another play on genetic-based medicine but instead… https://t.co/57uCdPcwGE April 14th 2021, 2:04pm |
|
@Tickeron $DRNA's 10-day Moving Average crossed below its 50-day Moving Average on March 26, 2021. View odds for this and oth… https://t.co/sHijyQg3Ci April 14th 2021, 4:04am |
|
@mediasentiment $DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 844 April 13th 2021, 11:04pm |
|
@humour_humourrr @sonichedgefund @mikegoodma I think they will recognize $180M in Q1 per latest 8-K $DRNA https://t.co/vgTSmBHOMO April 13th 2021, 4:04pm |
 |
@ShortAlgoKing $DRNA Waiting for buy signal. https://t.co/SI5wH2Z0TH April 13th 2021, 2:04pm |
 |
@mikegoodma At end of 2020 $DRNA had $568.8m in cash. It expects its balance sheet to remain strong due to product revs, paymen… https://t.co/DdJso9Enjo April 13th 2021, 1:04pm |
 |
@SwingTradeBot $DRNA technical alerts: Pocket Pivot, 50 DMA Resistance, Hammer Candlestick, 20 DMA Support, and ... https://t.co/SvLQTafHg8 April 13th 2021, 12:04pm |
|
@Tickeron $DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/QOZ5aG0L4M April 13th 2021, 6:04am |
 |
@EdgarInsider Alert [Press/News Current Report] / Form 8-K filed with the SEC $DRNA Dicerna Pharmaceuticals Inc https://t.co/xLlVo6NiSt April 12th 2021, 9:04pm |
 |
@FlashAlert_me $DRNA [15s. delayed] filed form 8-K on April 12, 17:16:27: Item1.01: Entry into a Material Definitive Agreement https://t.co/OyWp5bmTCl April 12th 2021, 9:04pm |
 |
@TradeWithAlerts Large Print $DRNA Size: 266036 Price: 26.18 Time: 1600 Amount: $6,964,822.48 April 12th 2021, 8:04pm |
|
@Tickeron $DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/g5GCa5tfJk April 12th 2021, 8:04am |
|
@Tickeron $DRNA in Uptrend: Stochastic indicator sits in overbought zone for 2 days. View odds for this and other indicators:… https://t.co/vnehYLcR8p April 9th 2021, 12:04pm |
|
@humour_humourrr $DRNA Company gets $180m cash influx and pps is up few cents ? That's all you need to know about current tape in small cap biotech. April 8th 2021, 6:04pm |
|
@stockhoot $DRNA SVB Leerink Maintains to Outperform : PT $44.00 https://t.co/9jDUhhrU6t April 8th 2021, 5:04pm |
 |
@SmallCapsDaily $DRNA Royalty Pharma Acquires OXLUMO Royalty Interest From Dicerna for up to $240 Million GlobeNewswire… https://t.co/VsBJUMWt1i April 8th 2021, 3:04pm |
|
@humour_humourrr @happyycamperr Exactly. It would have taken them years anyway to collect ~$200m from ALNY. $DRNA April 8th 2021, 12:04pm |
 |
@happyycamperr $DRNA great sale of royalty on Lumasiran for 180MM plus additional milestones.....put the money to work on higher… https://t.co/uGVy5UPnUl April 8th 2021, 12:04pm |
 |
@NewsQuantified $DRNA today announced that Royalty Pharma has acquired Dicerna’s royalty interest in OXLUMO™ (lumasiran) for an upf… https://t.co/QJJh1XctyQ April 8th 2021, 12:04pm |
 |
@Rickpilk Dicerna's $DRNA sale of the royalty interests for one its drugs together with Dicerna’s cash, cash equivalents, inv… https://t.co/GlIINwAQHq April 8th 2021, 11:04am |
 |
@otcdynamics $DRNA Dicerna Sells OXLUMO™ (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million https://t.co/w5JwVHlMuK April 8th 2021, 11:04am |
|
@FlashAlert_me $DRNA [15s. delayed]: Issued Press Release on April 08, 07:30:00: Dicerna Sells OXLUMO™ (lumasiran) Royalty Interes… https://t.co/iWGXOawjXl April 8th 2021, 11:04am |
|
@Tickeron $DRNA in Uptrend: Stochastic indicator is remaining in overbought zone for 1 day. View odds for this and other indi… https://t.co/8gzeAPn4IS April 8th 2021, 7:04am |
 |
@choochloves10x mRNA tech is going to be a miracle wasted on the anti-vaxers. Long $DRNA. https://t.co/z4NmYHhZ4V April 6th 2021, 4:04pm |
 |
@InsiderAlerts4U $DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Human Resources Officer REGINA M. PAGLIA: https://t.co/JHOeRTXT11 April 6th 2021, 1:04pm |
 |
@newsfilterio Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $DRNA https://t.co/kbwKIHVuX5 April 6th 2021, 4:04am |
|
@newsfilterio Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $DRNA https://t.co/ytuNzhyzpC April 6th 2021, 3:04am |
|
@newsfilterio Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $DRNA https://t.co/hOYCdCWbHy April 6th 2021, 3:04am |
 |
@formwhisperscom #FWSells $DRNA Brown Bob D, Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc sold 8,312 shares on 2021… https://t.co/wqyvPVAnGj April 6th 2021, 3:04am |
 |
@insiderbuyings $DRNA new insider selling: 8312 shares. https://t.co/ekM2hv6N69 April 6th 2021, 2:04am |
 |
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4/A https://t.co/q5WozoglAy April 6th 2021, 1:04am |
 |
@fintel_io Insider Bob D Brown reports selling 8,312 shares of $DRNA for a total cost of $215,025.46 https://t.co/glLrpbIqBp April 6th 2021, 1:04am |
|
@FlashAlert_me $DRNA [15s. delayed] filed SEC form 4/A: Chief Scientific Ofr., EVP R&D Brown Bob D: Converted securities 8,312 of… https://t.co/5Bi78ZQVh6 April 6th 2021, 1:04am |
|
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4/A https://t.co/RdQiW99e3W April 6th 2021, 1:04am |
|
@FlashAlert_me $DRNA [15s. delayed] filed SEC form 4/A: Chief Scientific Ofr., EVP R&D Brown Bob D: Converted securities 16,630 o… https://t.co/d4axmAF92w April 6th 2021, 1:04am |
|
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/IJ0qgyGx8V April 6th 2021, 1:04am |
|
@FlashAlert_me $DRNA [15s. delayed] filed SEC form 4: Chief Human Resources Officer Paglia Regina M.: Disposed 4,431 of Common St… https://t.co/BzO6Fr6Ash April 6th 2021, 1:04am |
|
@fintel_io Insider Paglia Regina M. reports selling 4,431 shares of $DRNA for a total cost of $114,563.95 https://t.co/qrW6FAKbEQ April 6th 2021, 1:04am |
|
@formwhisperscom #FWSells $DRNA Paglia Regina M., Chief Human Resources Officer of Dicerna Pharmaceuticals Inc sold 4,431 shares on… https://t.co/VdW7K77OIh April 6th 2021, 1:04am |
|
@Tickeron $DRNA in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on November 27, 2020. View odds for th… https://t.co/Hr7GBvpspW April 5th 2021, 11:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
